A 62-year-old with HFrEF remains symptomatic despite ACEi and beta-blocker. Resting HR 78 bpm, sinus rhythm, LVEF 28%. Which additive therapy improves...

Question

A 62-year-old with HFrEF remains symptomatic despite ACEi and beta-blocker. Resting HR 78 bpm, sinus rhythm, LVEF 28%. Which additive therapy improves outcomes?

Accepted Answer

Mineralocorticoid receptor antagonist (e.g., spironolactone)

Answer

Digoxin first

Answer

Non-dihydropyridine CCB

Answer

High-dose furosemide only

Answer

Nitrate monotherapy

ukmla MCQ (SBA): Heart Failure Optimisation

A 62-year-old with HFrEF remains symptomatic despite ACEi and beta-blocker. Resting HR 78 bpm, sinus rhythm, LVEF 28%. Which additive therapy improves outcomes?